Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?

Breast Cancer Res Treat. 2009 Mar;114(2):387-9. doi: 10.1007/s10549-008-0015-4. Epub 2008 Apr 26.
No abstract available

Publication types

  • Letter
  • Review

MeSH terms

  • Breast Neoplasms / blood supply*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Female
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Metformin / adverse effects
  • Metformin / therapeutic use*
  • Neovascularization, Pathologic / chemically induced*
  • Risk Factors

Substances

  • Hypoglycemic Agents
  • Metformin